#6

Essay: ‘Living Drug’ Gets Green Light

The FDA approves a powerful gene therapy to fight a resistant cancer.

RELATED TAGS: CANCER
cancer-cell
Immunotherapy, the hottest field in cancer research, seeks to supercharge the body’s natural defenses against deadly tumors. Two different approaches are driving the buzz, and one of them got a big boost in August when the Food and Drug Administration approved a “living drug” to treat acute lymphoblastic leukemia (ALL) in children and young adults who’ve stopped responding to chemotherapy. The product, dubbed tisagenlecleucel (pronounced tis-a-gen-LEK-loo-sell), is the f...
DSC-CV0218web

The full text of this article is available to Discover Magazine subscribers only.

Subscribe and get 10 issues packed with:
  • The latest news, theories and developments in the world of science
  • Compelling stories and breakthroughs in health, medicine and the mind
  • Environmental issues and their relevance to daily life
  • Cutting-edge technology and its impact on our future
Already a subscriber? Register now!
Registration is FREE and takes only a few seconds to complete. If you are already registered on DiscoverMagazine.com, please log in.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
DSC-CV0218web
+